Home Stock

Stock Research: Medartis Holding

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Medartis Holding

SWX:MED CH0386200239
31
  • Value
    7
  • Growth
    82
  • Safety
    Safety
    66
  • Combined
    60
  • Sentiment
    4
  • 360° View
    360° View
    31
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medartis Holding AG is a Switzerland-based medical device company manufacturing implants for fracture fixation. They operate in the medical devices and implants industry with product lines like APTUS (upper and lower extremities) and MODUS (cranio-maxillofacial surgery). Their products are sold globally in over 30 countries, including Germany and the United States. In the last fiscal year, the company had a market cap of $1349 million, profits of $197 million, revenue of $248 million, and 949 employees.

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Capital Growth
Country Switzerland
Industry Health Care Equipment
Size Small
Website medartis.com
Index
SPI
Medartis Holding stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
7 16 17 5
Growth
82 82 85 93
Safety
Safety
66 86 57 56
Sentiment
4 14 65 58
360° View
360° View
31 51 72 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
12 57 88 17
Opinions Change
14 28 50 92
Pro Holdings
n/a 16 42 45
Market Pulse
33 35 44 56
Sentiment
4 14 65 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
7 16 17 5
Growth
82 82 85 93
Safety Safety
66 86 57 56
Combined
60 76 57 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
16 37 38 16
Price vs. Earnings (P/E)
1 3 9 3
Price vs. Book (P/B)
26 37 34 32
Dividend Yield
1 1 1 1
Value
7 16 17 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
62 79 86 80
Profit Growth
9 100 100 98
Capital Growth
93 19 43 24
Stock Returns
83 56 35 100
Growth
82 82 85 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
48 67 80 78
Refinancing
80 76 49 55
Liquidity
43 74 25 23
Safety Safety
66 86 57 56

Similar Stocks

Discover high‑ranked alternatives to Medartis Holding and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Bachem

SWX:BANB
Country: Switzerland
Industry: Life Sciences Tools & Services
Size: Medium
Full Stock Analysis

Swatch

VTX:UHR
Country: Switzerland
Industry: Apparel, Accessories, Luxury
Size: X-Large
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews